Stock Price Quote

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1119.601.95 (+0.17 %)
PREV CLOSE ( ) 1117.65
OPEN PRICE ( ) 1117.50
BID PRICE (QTY) 1119.40 (2)
OFFER PRICE (QTY) 1119.95 (2)
VOLUME 53034
TODAY'S LOW / HIGH ( )1104.80 1128.00
52 WK LOW / HIGH ( )850 1121
NSE1120.704.85 (+0.43 %)
PREV CLOSE( ) 1115.85
OPEN PRICE ( ) 1119.75
BID PRICE (QTY) 1120.65 (87)
OFFER PRICE (QTY) 1120.70 (5)
VOLUME 1162161
TODAY'S LOW / HIGH( ) 1105.05 1128.00
52 WK LOW / HIGH ( )850 1121.65
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX

NEWS

23Sep Cipla gets EIR from USFDA for Indore p
Cipla has received the Establishment Inspection Report (EIR) for its Ind..
23Sep Cipla moves up on getting EIR from USF
Cipla is currently trading at Rs. 1071.00, up by 9.30 points or 0.88% fr..
14Sep Cipla informs about allotment under ESOP
Cipla has informed that the Operations and Administrative Committee of t..
13Sep Cipla informs about analyst meet
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
07Sep Cipla receives USFDA’s approval for Le
Cipla has received final approval for its Abbreviated New Drug Applicati..

Financials

in Millions
QTR Jun 22 ANNUAL 22
Net Profit7591.629579.3
Gross Profit 8653.9 35462.3
Operating Profit 9750.640331.7
Net Sales 31571.3130917.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  3115.10 (3.80%)
M.Cap ( in Cr)7622.00
Procter&Gamble Healt (BSE)
peergroup  4101.00 (2.37%)
M.Cap ( in Cr)6821.85
RPG Life Sciences (BSE)
peergroup  796.75 (9.32%)
M.Cap ( in Cr)1270.36
Pfizer (BSE)
peergroup  4287.45 (1.20%)
M.Cap ( in Cr)19131.70
Abbott India (BSE)
peergroup  19230.95 (0.22%)
M.Cap ( in Cr)40899.70

Shareholding Pattern

PROMOTERS 33.61%
FI/BANKS/INSURANCE 3.73%
NON-INSTITUTION 17.4%
MUTUAL FUNDS/UTI 13.39%
FII 0.01%
GOVERNMENT 0%

About Cipla Ltd.

Cipla Ltd. was incorporated in the year 1935. Its today's share price is 1119.6. Its current market capitalisation stands at Rs 89972.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 140084.9 Cr and Total Income of Rs.137584.9 Cr. The company's management includes Rajendra Chopra, Robert Stewart, Punita Lal, Peter Mugyenyi, PR Ramesh, Mandar Purushottam Vaidya, Ashok Sinha, Adil Zainulbhai, S Radhakrishnan, Umang Vohra, Samina Hamied, MK Hamied, Y K Hamied.

It is listed on the BSE with a BSE Code of 500087 , NSE with an NSE Symbol of CIPLA and ISIN of INE059A01026. It's Registered office is at Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower ParelMumbai-400013, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are RGN Price & Co, RS Bharucha & Co, V Sankar Aiyar & Co, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)